QQQ   347.64 (+0.89%)
AAPL   161.83 (+1.34%)
MSFT   303.38 (+2.25%)
FB   299.95 (+1.81%)
GOOGL   2,631.08 (+1.80%)
AMZN   2,855.90 (+2.82%)
TSLA   868.37 (-7.36%)
NVDA   223.04 (-2.06%)
BABA   113.39 (+0.02%)
NIO   21.72 (-4.15%)
AMD   105.28 (-4.90%)
CGC   6.97 (-3.60%)
MU   80.68 (-1.57%)
GE   89.84 (+0.58%)
T   24.33 (+0.33%)
F   19.88 (-0.15%)
DIS   137.01 (+2.55%)
AMC   14.91 (-6.46%)
PFE   54.26 (+2.36%)
ACB   3.90 (-3.94%)
BA   193.23 (-0.54%)
QQQ   347.64 (+0.89%)
AAPL   161.83 (+1.34%)
MSFT   303.38 (+2.25%)
FB   299.95 (+1.81%)
GOOGL   2,631.08 (+1.80%)
AMZN   2,855.90 (+2.82%)
TSLA   868.37 (-7.36%)
NVDA   223.04 (-2.06%)
BABA   113.39 (+0.02%)
NIO   21.72 (-4.15%)
AMD   105.28 (-4.90%)
CGC   6.97 (-3.60%)
MU   80.68 (-1.57%)
GE   89.84 (+0.58%)
T   24.33 (+0.33%)
F   19.88 (-0.15%)
DIS   137.01 (+2.55%)
AMC   14.91 (-6.46%)
PFE   54.26 (+2.36%)
ACB   3.90 (-3.94%)
BA   193.23 (-0.54%)
QQQ   347.64 (+0.89%)
AAPL   161.83 (+1.34%)
MSFT   303.38 (+2.25%)
FB   299.95 (+1.81%)
GOOGL   2,631.08 (+1.80%)
AMZN   2,855.90 (+2.82%)
TSLA   868.37 (-7.36%)
NVDA   223.04 (-2.06%)
BABA   113.39 (+0.02%)
NIO   21.72 (-4.15%)
AMD   105.28 (-4.90%)
CGC   6.97 (-3.60%)
MU   80.68 (-1.57%)
GE   89.84 (+0.58%)
T   24.33 (+0.33%)
F   19.88 (-0.15%)
DIS   137.01 (+2.55%)
AMC   14.91 (-6.46%)
PFE   54.26 (+2.36%)
ACB   3.90 (-3.94%)
BA   193.23 (-0.54%)
QQQ   347.64 (+0.89%)
AAPL   161.83 (+1.34%)
MSFT   303.38 (+2.25%)
FB   299.95 (+1.81%)
GOOGL   2,631.08 (+1.80%)
AMZN   2,855.90 (+2.82%)
TSLA   868.37 (-7.36%)
NVDA   223.04 (-2.06%)
BABA   113.39 (+0.02%)
NIO   21.72 (-4.15%)
AMD   105.28 (-4.90%)
CGC   6.97 (-3.60%)
MU   80.68 (-1.57%)
GE   89.84 (+0.58%)
T   24.33 (+0.33%)
F   19.88 (-0.15%)
DIS   137.01 (+2.55%)
AMC   14.91 (-6.46%)
PFE   54.26 (+2.36%)
ACB   3.90 (-3.94%)
BA   193.23 (-0.54%)
NASDAQ:HBIO

Harvard Bioscience Stock Forecast, Price & News

$5.67
+0.05 (+0.89%)
(As of 01/27/2022 12:06 PM ET)
Add
Compare
Today's Range
$5.67
$5.74
50-Day Range
$5.53
$7.58
52-Week Range
$3.87
$8.75
Volume
385 shs
Average Volume
181,205 shs
Market Capitalization
$231.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.75
30 days | 90 days | 365 days | Advanced Chart
Receive HBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter.


Harvard Bioscience logo

About Harvard Bioscience

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:HBIO
CUSIP
41690610
Employees
444
Year Founded
N/A

Sales & Book Value

Annual Sales
$102.10 million
Cash Flow
$0.30 per share
Book Value
$1.97 per share

Profitability

Net Income
$-7.81 million
Pretax Margin
-1.56%

Debt

Price-To-Earnings

Miscellaneous

Free Float
38,607,000
Market Cap
$231.40 million
Optionable
Optionable

Company Calendar

Last Earnings
11/02/2021
Today
1/27/2022
Next Earnings (Estimated)
3/09/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.09 out of 5 stars

Computer And Technology Sector

422nd out of 898 stocks

Analytical Instruments Industry

12th out of 33 stocks

Analyst Opinion: 2.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












Harvard Bioscience (NASDAQ:HBIO) Frequently Asked Questions

How has Harvard Bioscience's stock been impacted by Coronavirus?

Harvard Bioscience's stock was trading at $2.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HBIO shares have increased by 131.6% and is now trading at $5.72.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Harvard Bioscience?

Harvard Bioscience saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 607,700 shares, an increase of 19.5% from the December 15th total of 508,500 shares. Based on an average daily volume of 161,800 shares, the short-interest ratio is currently 3.8 days. Currently, 1.7% of the company's stock are short sold.
View Harvard Bioscience's Short Interest
.

When is Harvard Bioscience's next earnings date?

Harvard Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Harvard Bioscience
.

How were Harvard Bioscience's earnings last quarter?

Harvard Bioscience, Inc. (NASDAQ:HBIO) announced its quarterly earnings results on Tuesday, November, 2nd. The medical instruments supplier reported $0.06 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.06. The medical instruments supplier had revenue of $29.66 million for the quarter, compared to analyst estimates of $28.10 million. Harvard Bioscience had a negative net margin of 1.60% and a positive trailing twelve-month return on equity of 9.59%. During the same quarter in the previous year, the business earned $0.01 earnings per share.
View Harvard Bioscience's earnings history
.

What price target have analysts set for HBIO?

0 brokerages have issued twelve-month target prices for Harvard Bioscience's stock. Their forecasts range from $9.00 to $9.00. On average, they expect Harvard Bioscience's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 57.3% from the stock's current price.
View analysts' price targets for Harvard Bioscience
or view top-rated stocks among Wall Street analysts.

Who are Harvard Bioscience's key executives?

Harvard Bioscience's management team includes the following people:
  • James W. Green, Chairman, President & Chief Executive Officer
  • Kenneth F. Olson, COO, Senior VP-Global Operations & Engineering
  • Michael A. Rossi, Chief Financial Officer
  • Don Stewart, Vice President-North Americas & APAC Sales
  • Ryan Wallace, Vice President-Global Sales, Preclinical Systems

What other stocks do shareholders of Harvard Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Harvard Bioscience investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), NVIDIA (NVDA), LightPath Technologies (LPTH), Micron Technology (MU), Nokia (NOK), Evoke Pharma (EVOK), General Electric (GE) and Gilead Sciences (GILD).

What is Harvard Bioscience's stock symbol?

Harvard Bioscience trades on the NASDAQ under the ticker symbol "HBIO."

Who are Harvard Bioscience's major shareholders?

Harvard Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include AMH Equity Ltd (1.96%) and Strs Ohio (0.26%). Company insiders that own Harvard Bioscience stock include Alan I Edrick and James W Green.
View institutional ownership trends for Harvard Bioscience
.

Which institutional investors are buying Harvard Bioscience stock?

HBIO stock was bought by a variety of institutional investors in the last quarter, including AMH Equity Ltd, and Strs Ohio. Company insiders that have bought Harvard Bioscience stock in the last two years include Alan I Edrick, and James W Green.
View insider buying and selling activity for Harvard Bioscience
or or view top insider-buying stocks.

How do I buy shares of Harvard Bioscience?

Shares of HBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Harvard Bioscience's stock price today?

One share of HBIO stock can currently be purchased for approximately $5.72.

How much money does Harvard Bioscience make?

Harvard Bioscience has a market capitalization of $233.44 million and generates $102.10 million in revenue each year. The medical instruments supplier earns $-7.81 million in net income (profit) each year or ($0.05) on an earnings per share basis.

How many employees does Harvard Bioscience have?

Harvard Bioscience employs 444 workers across the globe.

What is Harvard Bioscience's official website?

The official website for Harvard Bioscience is www.harvardbioscience.com.

Where are Harvard Bioscience's headquarters?

Harvard Bioscience is headquartered at 84 OCTOBER HILL RD, HOLLISTON MA, 01746.

How can I contact Harvard Bioscience?

Harvard Bioscience's mailing address is 84 OCTOBER HILL RD, HOLLISTON MA, 01746. The medical instruments supplier can be reached via phone at (508) 893-8999, via email at [email protected], or via fax at 508-429-5732.


This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.